Suchergebnisse - "Bai, Lang"

PubPharm (11)

1

Pegylated interferon-α-2b combined with tenofovir disoproxil fumarate, granulocyte-macrophage colony-stimulating factor, and hepatitis B vaccine treatment for naïve HBeAg-positive chronic hepatitis B patients : A prospective, multicenter, randomized controlled study

enthalten in: Journal of medical virology | 2022

von Lian, J. | Kuang, W. | Jia, H. | +17

2

Efficacy of different nucleoside analog rescue therapies for entecavir-resistant chronic hepatitis B patients

enthalten in: BMC infectious diseases | 2021

von Shang, J. | Zhou, J. | Liu, H. | +5

3

Sofosbuvir plus Ribavirin is effective for HCV elimination in people living with HIV from rural area of China

enthalten in: Scientific reports | 2021

von Chen, L. | Du, L. | Kang, S. | +5

4

Analysis of long-term safety and efficacy of nucleos(t)ide analogue therapy for chronic hepatitis B throughout pregnancy

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2021

von Shang, J. | Liu, H. | Wen, Q. | +4

5

A Tenofovir-Loaded Glycyrrhetinic Acid-Modified Cationic Liposome for Targeted Therapy of Hepatitis B Virus

enthalten in: Journal of biomedical nanotechnology | 2020

von Yao, D. | Liu, D. | Luo, R. | +13

6

Combination of entecavir with thymosin alpha-1 in HBV-related compensated cirrhosis : a prospective multicenter randomized open-label study

enthalten in: Expert opinion on biological therapy | 2018

von Wu, X. | Shi, Y. | Zhou, J. | +22

7

High value of controlled attenuation parameter predicts a poor antiviral response in patients with chronic hepatits B

enthalten in: Hepatobiliary & pancreatic diseases international : HBPD INT | 2017

von Chen, J. | Wang, M. | Long, Q. | +2

8

Low Ratio of Treg to Th17 Cells After 36 Weeks of Telbivudine Therapy Predict HBeAg Seroconversion

enthalten in: Viral immunology | 2016

von Wang, M. | Zhou, Q. | Chen, E. | +5

9

Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo

enthalten in: Molecular medicine reports | 2015

von Leng, X. | Chen, E. | Du, L. | +5

10

Efficacy of entecavir treatment for up to 96 weeks in nucleoside-naive HBeAg-positive chronic hepatitis B patients with high viral load

enthalten in: Clinics and research in hepatology and gastroenterology | 2015

von Yan, L. | Chen, E. | Bai, L. | +5